The White House has assured this Tuesday that the decision of the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) to paralyze the Johnson & Johnson vaccine "will not have a significant impact" on his plans to immunize the population in the United States.
"The Johnson & Johnson vaccine represents less than 5% of the vaccines registered in the United States to date," Jeff Zients, White House COVID-19 Response Coordinator, said in a statement.
The FDA and CDC this morning recommended stopping the use of this vaccine after six people experienced "a rare and severe type of blood clot" after receiving the injection.
Zients said the United States has enough doses of Pfizer and Moderna vaccines (the other two licensed) to immunize 300 million people.
"In recent weeks, we have made more than 25 million doses of Pfizer and Moderna available each week, and in fact this week we will make 28 million doses of these vaccines available," he added.
He also specified that the country will continue with the current rate of three million vaccines administered per day, to meet the goal of the president, Joe Biden, of "reaching all adults who want to be vaccinated" during the month of April.
The White House also assured that it is working with federal and state authorities so that anyone who has been scheduled for a J&J vaccine is quickly rescheduled for a Pfizer or Moderna vaccine.